PT1293507E - Processo para produção de cristais - Google Patents

Processo para produção de cristais Download PDF

Info

Publication number
PT1293507E
PT1293507E PT01930131T PT01930131T PT1293507E PT 1293507 E PT1293507 E PT 1293507E PT 01930131 T PT01930131 T PT 01930131T PT 01930131 T PT01930131 T PT 01930131T PT 1293507 E PT1293507 E PT 1293507E
Authority
PT
Portugal
Prior art keywords
producing crystal
crystal
producing
Prior art date
Application number
PT01930131T
Other languages
English (en)
Inventor
Hideo Hashimoto
Hideaki Maruyama
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of PT1293507E publication Critical patent/PT1293507E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
PT01930131T 2000-05-15 2001-05-15 Processo para produção de cristais PT1293507E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000141670 2000-05-15

Publications (1)

Publication Number Publication Date
PT1293507E true PT1293507E (pt) 2008-01-16

Family

ID=18648753

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01930131T PT1293507E (pt) 2000-05-15 2001-05-15 Processo para produção de cristais

Country Status (12)

Country Link
US (4) US7169799B2 (pt)
EP (3) EP2281821B1 (pt)
KR (2) KR20080067713A (pt)
CN (2) CN1280287C (pt)
AU (1) AU2001256732A1 (pt)
CA (3) CA2409044C (pt)
CY (1) CY1107198T1 (pt)
DE (1) DE60131649T2 (pt)
DK (1) DK1293507T3 (pt)
ES (3) ES2511774T3 (pt)
PT (1) PT1293507E (pt)
WO (1) WO2001087874A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169799B2 (en) * 2000-05-15 2007-01-30 Takeda Pharmaceutical Company Limited Process for producing crystal
ATE342263T1 (de) 2000-08-04 2006-11-15 Takeda Pharmaceutical Salze von benzimidazol-derivaten und deren verwendung
CN1254473C (zh) 2000-12-01 2006-05-03 武田药品工业株式会社 (r)－或(s)－兰索拉唑的结晶方法
EP2596792A1 (en) * 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
JP2006514108A (ja) * 2002-12-19 2006-04-27 テバ ファーマシューティカル インダストリーズ リミティド パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
US7994159B2 (en) * 2003-03-10 2011-08-09 Eisai R&D Management Co., Ltd. c-Kit kinase inhibitor
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
WO2006009602A2 (en) * 2004-06-16 2006-01-26 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
EP1862456A4 (en) * 2005-03-22 2010-01-27 Daiichi Sankyo Co Ltd PROCESS FOR PREPARING A CARBAPENE DERIVATIVE WITH 1-ALKYLPYRROLIDINE STRUCTURE
TW200639176A (en) * 2005-05-13 2006-11-16 Sankyo Co Crystal of 1-methyl carbapenem compound
US20090030044A1 (en) * 2005-06-07 2009-01-29 Takeda Pharmaceutical Company Limited Crystal of Salt of Benzimidazole Compound
ZA200805646B (en) 2005-12-28 2009-12-30 Takeda Pharmaceutical Controlled release solid preparation
EP2098250B1 (en) 2006-12-28 2016-09-28 Takeda Pharmaceutical Company Limited Orally disintegrating solid preparation
CN104069088A (zh) * 2007-10-12 2014-10-01 武田制药北美公司 与食物摄入无关的治疗胃肠病症的方法
US8214093B2 (en) * 2007-11-04 2012-07-03 GM Global Technology Operations LLC Method and apparatus to prioritize transmission output torque and input acceleration for a hybrid powertrain system
EP2227462A1 (en) * 2007-12-31 2010-09-15 Takeda Pharmaceutical Company Limited Crystalline solvated forms of (r) -2- [[[3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl]methyl]sulfinyl]-1h-benz imidazole
LT2262790T (lt) * 2008-03-10 2017-08-25 Takeda Pharmaceutical Company Limited Benzimidazolo junginio kristalas
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
IT1391776B1 (it) 2008-11-18 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo
IT1392813B1 (it) 2009-02-06 2012-03-23 Dipharma Francis Srl Forme cristalline di dexlansoprazolo
US20110009637A1 (en) * 2009-02-10 2011-01-13 Dario Braga Crystals of Dexlansoprazole
WO2011004387A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd Process for the preparation of dexlansoprazole polymorphic forms
IT1395118B1 (it) 2009-07-29 2012-09-05 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino
US20130197232A1 (en) * 2010-01-29 2013-08-01 Ranbaxy Laboratories Limited Process for the preparation of crystalline forms of dexlansoprazole
EP2552903A1 (en) 2010-03-31 2013-02-06 Ranbaxy Laboratories Limited Salts of dexlansoprazole and their preparation
US8853411B2 (en) 2010-03-31 2014-10-07 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
EP2647381A4 (en) 2010-12-03 2015-12-23 Takeda Pharmaceutical MELTING TABLET
US20130273157A1 (en) 2010-12-27 2013-10-17 Takeda Pharmaceutical Company Limited Orally disintegrating tablet
WO2012104805A1 (en) 2011-02-01 2012-08-09 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
EP2723728A1 (en) 2011-06-21 2014-04-30 Ranbaxy Laboratories Limited Process for the preparation of dexlansoprazole
CN102234265B (zh) * 2011-08-08 2013-11-20 天津市汉康医药生物技术有限公司 兰索拉唑化合物
ES2561098T3 (es) 2011-11-30 2016-02-24 Takeda Pharmaceutical Company Limited Comprimido recubierto en seco
WO2013140120A1 (en) 2012-03-22 2013-09-26 Cipla Limited Glycerol solvate forms of (r) - 2 - [ [ [3 -methyl -4 (2,2, 2 - trifluoroethoxy) pyridin- 2 - yl] methyl] sulphinyl] - 1h - ben zimidazole
WO2013179194A1 (en) 2012-05-31 2013-12-05 Ranbaxy Laboratories Limited Process for the preparation of crystalline dexlansoprazole
WO2014189034A1 (ja) 2013-05-21 2014-11-27 武田薬品工業株式会社 口腔内崩壊錠
DE102014109120B4 (de) 2014-06-30 2017-04-06 Krohne Messtechnik Gmbh Mikrowellenmodul
CN109111430B (zh) * 2017-06-26 2022-09-30 江苏豪森药业集团有限公司 一种右兰索拉唑晶型a及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
TW385306B (en) * 1996-11-14 2000-03-21 Takeda Chemical Industries Ltd Method for producing crystals of benzimidazole derivatives
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
JP3929607B2 (ja) 1997-07-23 2007-06-13 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピリジン誘導体の製造方法
JP2002501896A (ja) 1998-01-30 2002-01-22 セプラコール， インク． Ｓ−ランソプラゾール組成物及び方法
EP1056456A4 (en) 1998-01-30 2006-10-25 Sepracor Inc R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
TWI275587B (en) * 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
US6608092B1 (en) * 1999-06-30 2003-08-19 Takeda Chemical Industries, Ltd. Crystals of benzimidazole compounds
US7169799B2 (en) * 2000-05-15 2007-01-30 Takeda Pharmaceutical Company Limited Process for producing crystal
CN1254473C (zh) * 2000-12-01 2006-05-03 武田药品工业株式会社 (r)－或(s)－兰索拉唑的结晶方法
WO2007059421A2 (en) * 2005-11-10 2007-05-24 Wyeth Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl) amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same

Also Published As

Publication number Publication date
KR20090076980A (ko) 2009-07-13
CN1280287C (zh) 2006-10-18
DE60131649D1 (de) 2008-01-10
DK1293507T3 (da) 2007-12-27
KR20080067713A (ko) 2008-07-21
EP1293507A1 (en) 2003-03-19
CN1803137A (zh) 2006-07-19
EP1293507B1 (en) 2007-11-28
EP1293507A4 (en) 2005-09-07
US20070004779A1 (en) 2007-01-04
US7994332B2 (en) 2011-08-09
CN1437592A (zh) 2003-08-20
EP1897877B1 (en) 2014-09-24
EP2281821A1 (en) 2011-02-09
US20100004458A1 (en) 2010-01-07
CN100562318C (zh) 2009-11-25
CA2762960A1 (en) 2001-11-22
CA2409044C (en) 2013-02-19
ES2511774T3 (es) 2014-10-23
US8212046B2 (en) 2012-07-03
CA2701704C (en) 2011-09-06
DE60131649T2 (de) 2008-10-30
US7569696B2 (en) 2009-08-04
US7169799B2 (en) 2007-01-30
CY1107198T1 (el) 2012-11-21
CA2701704A1 (en) 2001-11-22
EP2281821B1 (en) 2014-10-22
CA2762960C (en) 2014-07-22
EP1897877A2 (en) 2008-03-12
US20030153766A1 (en) 2003-08-14
CA2409044A1 (en) 2002-11-14
AU2001256732A1 (en) 2001-11-26
WO2001087874A1 (fr) 2001-11-22
KR101035534B1 (ko) 2011-05-23
EP1897877A3 (en) 2008-12-10
US20110257405A1 (en) 2011-10-20
ES2521690T3 (es) 2014-11-13
ES2293988T3 (es) 2008-04-01

Similar Documents

Publication Publication Date Title
PT1293507E (pt) Processo para produção de cristais
HUP0204295A3 (en) Process for producing l-lysine
EP1245606A4 (en) POLYESTER CONTINUOUS PRODUCTION PROCESS
EP1298217A4 (en) GLYCOPROTEIN PRODUCTION PROCESS
AU8451401A (en) Process for producing ester
HUP0103295A3 (en) Process for producing citalopram
HUP0104566A3 (en) Process for producing n-carboxi-anhidrides
HK1049327A1 (zh) 製備氨基二苯基胺的方法
EP1193332A4 (en) PROCESS FOR PRODUCING SILICON MONOCRYSTAL
PL361146A1 (en) Method for producing isocyanato-organosilanes
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
IL146027A0 (en) Process for preparing imidachloprid
EP1229011A4 (en) A PROCESS FOR THE PRODUCTION OF STYRENE
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
IL158288A0 (en) Process for producing thiosemicarbazides
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
EP1273611A4 (en) METHOD FOR PRODUCING POLYIMIDE
IL144264A0 (en) Process for producing quinolinecarbaldehyde
EP1114884A4 (en) Process for producing compound semiconductor single crystal
GB2363379B (en) Process for producing alpha-aminoketones
HU0104563D0 (en) Process for producing of food-enzymes
AU4273501A (en) Process for producing camptothecin
AU8444201A (en) Process for producing fluoroalkanol
AU7265900A (en) Method for producing otoplastics